Bijoy Hans Peer Comparison

BSE: 524723

₹134.05

₹6.35 (4.97%)

As on 23-Sep-2026 12:50IST

Market cap

₹644 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

P/B Ratio

11.3

Div. Yield

0 %

Edit

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Market cap (₹ Cr)	644	37,454	27,635	26,133	28,071
Revenue (₹ Cr)	0	3,564	1,936	1,462	9,205
Net Profit (₹ Cr)	-1.99	414.00	288.22	387.35	-371.81
Net Margin (%)	-668.12	11.23	14.79	26.01	-3.93
RoE (%)	-5.98	8.38	29.77	25.18	-3.85
Price to Earnings	--	91.58	95.88	67.66	--
Price-To-Book	11.27	7.44	20.59	15.15	3.51

Income Statement (₹ Cr)

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Operating Revenue	0.10	3,564.00	1,935.80	1,461.80	9,205.28
Total Income	0.30	3,686.00	1,948.58	1,489.25	9,449.59
Total Expenditure	2.14	2,792.00	1,485.56	919.25	8,195.15
EBITDA	-2.04	772.00	450.24	542.56	1,010.13
Depreciation	0.00	226.00	50.83	37.68	857.51
EBIT	-2.04	546.00	399.41	504.88	152.62
Interest	0.15	217.00	40.84	3.77	342.73
Other Income	0.20	122.00	12.78	27.45	244.31
Exceptional Items	0.00	12.00	0.00	0.00	-216.88
Profit before Tax	-1.99	463.00	371.35	528.56	-162.68
Provision for Tax	0.00	49.00	83.14	141.21	209.13
Profit after Tax	-1.99	414.00	288.22	387.35	-371.81

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Shareholder's Funds	58.00	4,940.00	1,288.82	1,653.56	8,162.62
Minority Interest	0.00	-5.00	0.00	-1.13	0.00
Non-Current Liabilities	0.00	1,712.00	202.03	42.40	5,044.14
Current Liabilities	10.38	1,622.00	835.87	230.82	4,758.28
Total Liabilities	3.59	8,100.00	1,451.43	1,549.26	15,513.53

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Non-Current Assets	60.78	5,343.00	519.60	1,026.85	10,211.52
Current Assets	7.59	2,606.00	1,681.81	881.27	7,191.66
Total Assets	3.59	8,100.00	1,451.43	1,549.26	15,513.53
Total Debt*	0.00	1,859.00	393.17	8.18	4,720.27
Net Current Assets	-2.79	984.00	845.94	650.46	2,433.38
Contingent Liabilities	--	770.26	12.25	15.38	99.76

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Cash From Operating Activities	0.22	-22.00	159.18	118.34	892.30
Cash Flow from Investing Activities	0.92	-783.00	-64.81	-223.94	-477.46
Cash from Financing Activities	-0.06	409.00	-39.81	261.12	-440.83
Net Cash Inflow / Outflow	1.08	-396.00	54.56	155.52	-25.99

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
ROCE (%)	5.74	4.07	26.97	20.14	6.61
ROE (%)	-5.98	8.38	29.77	25.18	-3.85
ROA (%)	-5.53	4.94	24.77	21.93	-2.21
EBIT Margin (%)	-2,043.00	15.32	20.63	34.54	1.66
Net Margin (%)	-668.12	11.23	14.79	26.01	-3.93
Cash Profit Margin (%)	57.56	0.00	0.00	0.00	0.00

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Revenue Growth (%)	-48.19	18.37	46.65	40.90	0.78
EBIT Growth (%)	-182.18	252.26	62.13	124.50	-70.53
Net Profit Growth (%)	-3,010.94	377.85	89.49	104.15	-1,383.43
EPS Growth (%)	39.91	1,001.33	78.60	42.32	-484.84
Book Value Growth (%)	4.01	29.77	42.49	94.96	2.28

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Price / Earnings	-135.20	89.10	94.55	68.11	-89.41
Price / Book Value	10.74	7.05	20.62	15.25	3.50
Dividend Yield (%)	0.00	0.00	0.09	0.08	0.00
EV/EBITDA	-298.84	47.88	61.28	48.12	31.80
Market Cap (₹ Cr)	0.00	23,064.69	0.00	19,988.69	29,731.27

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Debt to Equity	0.00	0.31	0.11	0.01	0.53
Short term debt to equity ratio	--	0.11	0.54	0.02	0.12
Current Ratio	0.73	1.61	2.01	3.82	1.51
Quick Ratio	0.73	1.06	1.14	2.82	0.87
Interest Coverage	-12.64	3.13	10.09	141.16	0.53

	Bijoy Hans	Wockhardt	Rubicon Research	Acutaas Chemicals	Piramal Pharma
Debtors to sales (%)	0.00	16.50	26.28	24.80	23.44
Asset Turnover	0.00	0.43	1.66	0.83	0.55
Receivable days	0.00	60.36	47.59	90.06	77.05
Inventory Days	0.00	64.42	62.58	61.02	77.13
Payable days	--	218.94	228.78	96.06	173.49
Cash Conversion Cycle	--	-94.15	-118.62	55.02	-19.30

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.